Work

Protocol to establish patient-derived xenograft and organoid for radiosensitivity of esophageal squamous cell carcinoma

Year: 2024
Type: article
Abstract: Patient-derived xenograft (PDX) and organoids derived from PDX (PDXOs) are ideal pre-clinical models, which recapitulate the tumor heterogeneity. We provide the steps to establish PDX and PDXOs from patients with esophageal squamous cell carcinoma (ESCC) and their utility in examining radiotherapy. We describe steps for generating ESCC-PDXs, four cycles of ionizing radiation treatments using X-ray on PDX, and evaluating radiosensitivity of PDXs. We then detail procedures for establishing and characterizing radioresistant organoids derived from PDX. For complete details on the use and execution of this protocol, please refer to Liu et al., 1 Yang et al., 2 and Chen et al. 3 • Guide to ESCC PDX model construction, characteristic, and maintenance • Steps for using X-ray on PDX to perform four cycles of ionizing radiation treatments • Instructions for evaluating PDX radiosensitivity by RTV and tumor growth inhibition • Procedures to establish and characterize PDXOs derived from PDX Publisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics. Patient-derived xenograft (PDX) and organoids derived from PDX (PDXOs) are ideal pre-clinical models, which recapitulate the tumor heterogeneity. We provide the steps to establish PDX and PDXOs from patients with esophageal squamous cell carcinoma (ESCC) and their utility in examining radiotherapy. We describe steps for generating ESCC-PDXs, four cycles of ionizing radiation treatments using X-ray on PDX, and evaluating radiosensitivity of PDXs. We then detail procedures for establishing and characterizing radioresistant organoids derived from PDX.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W4402698220
FWCI: 0.759
Cites: 9
Cited by: 2
Related to: 10